POCTA submits request that CMS update the medically unlikely edit (MUE) from one (1) to three (3) for CPT code – 87494 – for multiplex amplified probe tests that detect and report individual results for chlamydia and gonorrhea.
POCTA submits a request that CMS establish a medically unlikely edit (MUE) of three (3) for new CPT code – 87494 – for multiplex amplified probe tests that detect and report individual results for chlamydia and gonorrhea.
POCTA writes follow-up letter to Centene requesting revisions to its Physician’s Office Lab Testing Policy to add certain codes to its list of covered services when performed by a physician office laboratory.
POCTA joins more than 30 organizations in letter of support for the RESULTS Act.
POCTA sent a letter to CMS requesting the agency update the NCCI manual to reflect coding changes recently approved by the CPT Editorial Panel on HPV testing.
POCTA submitted comments supporting the preliminary determinations for six CPT codes related to infectious agents and traumatic brain injury.
POCTA submitted comments supporting the finalized CLFS payment rates for five tests for neurodegenerative disease. These tests saw an increase in payment from the proposed rates.
POCTA submits comment letter for the CY2026 Medicare Physician Fee Schedule (MPFS) proposed rule.
POCTA submits comment letter for the CY2026 Medicare Hospital Outpatient Prospective Payment System (OPPS) proposed rule.
POCTA leads stakeholder letter to Horizon BCBS on coverage for POC respiratory pathogen testing.